How AI Is Unlocking Drug Discovery from Existing Molecules

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Unfollow podcast failed

How AI Is Unlocking Drug Discovery from Existing Molecules

Listen for free

View show details

Lucas and Luna explore how pharmaceutical companies and startups are using artificial intelligence to find new therapeutic uses for drugs already approved for other conditions. They focus on a specific case: a 2025 study where an AI model screened 4,000 existing compounds and identified a common blood pressure medication as a potential treatment for a rare genetic liver disease — cutting the typical discovery timeline from years to months. The hosts discuss the economics of repurposing versus developing new drugs, the data infrastructure needed, and why this approach could reshape how we think about pharmaceutical R&D. No hype — just the real mechanics of computational drug repurposing and what it means for patients and investors. #DrugDiscovery #AIinHealthcare #PharmaceuticalR&D #DrugRepurposing #MachineLearning #ComputationalBiology #RareDisease #ClinicalTrials #HealthTech #Biotech #PharmaInnovation #PrecisionMedicine #DataScience #GenerativeAI #LifeSciences #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

No reviews yet